The US government is paying Siga $113 million to stockpile additional courses of the smallpox and mpox treatment known as Tpoxx.
The project falls under …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SEOUL, South Korea — Treatment with the bispecific antibody ubamatamab alone or in combination with the PD-1 inhibitor cemiplimab (Libtayo) appeared to be safe and
Rare neurological disease drug developer Harmony Biosciences acquired Epygenix Therapeutics and its pipeline of treatments for rare epilepsy conditions. Harmony paid $35 million upfront, and
A clinical trial at Oregon Health & Science University suggests that a subset of older adults with a genetic predisposition to Alzheimer’s disease may benefit